In particular, the concurrent use of additional polarization markers, such as CD206, may enable more accurate identification of TAM (tumor-associated macrophage) subtypes and help clarify their contribution to microenvironment remodeling, suppression of anti-tumor immune responses, and the development of prognostic models [23]. This evidence concerns the gene MRC1 and neoplasm.